Inspections

FDA Form 483 and warning letters: what they mean and how to respond

By Tristan Kleinberger2 min read

Short answer

An FDA Form 483 lists the inspectional observations an investigator made that may indicate violations. A warning letter is a formal notice that FDA considers violations significant and expects prompt correction. A strong 483 response, sent within 15 business days, is often what keeps an inspection from becoming a warning letter.

Form 483 vs warning letter

Form 483Warning letter
Issued byThe investigator, at the close of the inspectionFDA, after reviewing the inspection and your response
What it isObservations, not a final agency determinationFDA's position that significant violations occurred
Public?Available on request and in FDA's data releasesPublished on FDA's website
ResponseWithin 15 business days to be considered before further actionWithin 15 business days
If unresolvedCan lead to a warning letterCan lead to import alerts, seizure, or injunction

What happens after an inspection

The investigator reviews observations with management at a close-out meeting and issues the 483. FDA then classifies the inspection as No Action Indicated (NAI), Voluntary Action Indicated (VAI), or Official Action Indicated (OAI). An OAI classification is where warning letters and other regulatory actions come from.

How to write a strong 483 response

  1. Respond in writing within 15 business days
  2. Address each observation separately
  3. Investigate the root cause and check whether the problem is systemic, not just the cited example
  4. State corrections and corrective actions with owners and dates
  5. Attach evidence: revised SOPs, training records, investigation reports
  6. Explain how you will verify the actions worked
  7. Commit to realistic timelines and send updates as you complete them

Most of this is CAPA work, done under a deadline.

Learning from other companies' observations

FDA publishes warning letters and inspection observation data, so other companies' findings show where investigators are looking. For drug manufacturers, quality unit responsibilities (211.22), investigations (211.192), and written procedures (211.100) come up again and again. For supplement makers, specifications and identity testing under Part 111 lead the list.

Ovada's continuous quality monitoring compares relevant observations with the processes in your scope so a peer's 483 becomes your early warning.

Questions

How long do you have to respond to an FDA Form 483?

There is no legal deadline, but FDA considers responses received within 15 business days of the 483 before deciding whether to take further action, such as a warning letter.

Are FDA warning letters public?

Yes. FDA posts warning letters on its website, with some information redacted.

Does a Form 483 mean you failed the inspection?

Not by itself. A 483 lists observations. The inspection's outcome is the classification FDA assigns afterward: NAI, VAI, or OAI.

See Ovada at work

Find the gap before an investigator does

See how Ovada monitors procedures, records, and relevant FDA observations between inspections.